Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
665.00    -7.00 (-1.04%)
Bid:
664.00
Ask:
666.00
Spread: 2.00 (0.301%)
Market Cap: £541.28m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

8 Dec 2025 10:05

RNS Number : 6484K
Bloomsbury Publishing PLC
08 December 2025
 

08 December 2025

 

Bloomsbury Publishing Plc (the "Company")

 

Director/PDMR Shareholdings

 

The Company was made aware today that, as part of a dividend reinvestment plan, John Bason, the Company's Non-executive Chairman, purchased 90 ordinary shares of £0.0125 ("Ordinary Shares") on the market at a price of 496.84 pence per Ordinary Share on 28 November 2025. Following this transaction, he (including persons closely associated with him) holds a total of 23,109 shares in the Company, representing approximately 0.03% of the current Issued Share Capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation), which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Bason

2

Reason for the notification

a)

Position/status

Non-executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Share purchase

 

c)

Price(s) and volume(s)

Price

No. of shares

£4.9684

90

d)

Aggregated information

 

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

AQSE Trading (Equity)

 

 

 For further information, please contact:

Bloomsbury Publishing Plc

Maya Abu-Deeb, Group General Counsel & Company Secretary

maya.abu-deeb@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Hattie Dreyfus / Emily Brooker

bloomsbury@hudsonsandler.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGBDDDGGDGUI
Date   Source Headline
1st Jun 20239:34 amRNSDirector Declaration
31st May 20232:04 pmRNSInvestor Presentation
31st May 20237:00 amRNSAudited Preliminary Results
16th May 20237:00 amRNSNotice of Capital Markets Event
2nd May 20232:43 pmRNSNotice of Results
12th Apr 20233:16 pmRNSHolding(s) in Company
11th Apr 202310:03 amRNSHolding(s) in Company
15th Mar 20237:00 amRNSTrading Update
1st Mar 20237:00 amRNSNotice of Trading Update
17th Feb 20232:09 pmRNSBLOCK LISTING SIX MONTHLY RETURN
11th Jan 20239:08 amRNSHolding(s) in Company
18th Nov 20222:29 pmRNSHolding(s) in Company
14th Nov 20225:16 pmRNSHolding(s) in Company
2nd Nov 20222:56 pmRNSDirector/PDMR Shareholding
1st Nov 20225:16 pmRNSHolding(s) in Company
31st Oct 20227:00 amRNSInvestor Presentation
27th Oct 20221:02 pmEQSBloomsbury Publishing pleased with 'surge in the numbers'
26th Oct 20227:00 amRNSUnaudited Interim Results
14th Oct 202212:41 pmRNSHolding(s) in Company
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Sep 202211:16 amRNSHolding(s) in Company
24th Aug 20225:01 pmRNSDirector/PDMR Shareholding
22nd Aug 20224:16 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSBlock Listing Six Monthly Return
10th Aug 20225:22 pmRNSDirector/PDMR Shareholding
29th Jul 20225:25 pmRNSHolding(s) in Company
20th Jul 20224:32 pmRNSResults of the 2022 Annual General Meeting
20th Jul 20227:00 amRNSAGM Trading Update
4th Jul 20223:52 pmRNSNotice of AGM Clarification
1st Jul 20227:00 amRNSBloomsbury wins Small Cap Award
28th Jun 20224:42 pmRNSAnnual Financial Report
15th Jun 20227:00 amRNSAudited Preliminary Results
25th May 202210:50 amRNSDirector Declaration
24th May 20227:00 amRNSNotice of Results
26th Apr 20224:22 pmRNSHolding(s) in Company
25th Apr 202211:52 amRNSHolding(s) in Company
22nd Apr 20222:12 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSTrading Update
11th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Feb 20222:50 pmRNSBlock Listing Six Monthly Return
26th Jan 20227:00 amRNSTrading Update
19th Jan 20225:45 pmRNSHolding(s) in Company
16th Dec 20217:00 amRNSAcquisition
27th Oct 20217:00 amRNSUnaudited Interim Results
27th Oct 20217:00 amRNSInvestor Presentation
8th Oct 20218:00 amRNSAbdulrazak Gurnah wins Nobel Prize in Literature
26th Aug 20219:28 amRNSDirector/PDMR Shareholding
17th Aug 20211:49 pmRNSBlock Listing Six Monthly Return
13th Aug 20215:58 pmRNSDirector/PDMR Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.